Josephine Ann Carew, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Factor VII | 12 | 2012 | 139 | 1.680 |
Why?
|
| Myenteric Plexus | 1 | 2021 | 49 | 0.740 |
Why?
|
| Factor VII Deficiency | 7 | 2002 | 31 | 0.550 |
Why?
|
| Stomach | 1 | 2021 | 701 | 0.540 |
Why?
|
| Response Elements | 2 | 2012 | 308 | 0.410 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2012 | 86 | 0.390 |
Why?
|
| Gastric Fundus | 2 | 2021 | 37 | 0.300 |
Why?
|
| Transcription, Genetic | 5 | 2012 | 7609 | 0.290 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2007 | 102 | 0.280 |
Why?
|
| Promoter Regions, Genetic | 6 | 2007 | 5789 | 0.240 |
Why?
|
| 5' Flanking Region | 1 | 2003 | 31 | 0.220 |
Why?
|
| Up-Regulation | 1 | 2012 | 4142 | 0.210 |
Why?
|
| Glucose | 2 | 2012 | 4340 | 0.210 |
Why?
|
| Receptors, Steroid | 1 | 2003 | 157 | 0.200 |
Why?
|
| Sp1 Transcription Factor | 1 | 1998 | 143 | 0.150 |
Why?
|
| DNA-Binding Proteins | 5 | 2003 | 9611 | 0.150 |
Why?
|
| von Willebrand Factor | 2 | 1992 | 680 | 0.150 |
Why?
|
| Transfection | 7 | 2007 | 5754 | 0.140 |
Why?
|
| Genes, Reporter | 3 | 2007 | 1525 | 0.130 |
Why?
|
| Phosphoproteins | 3 | 2003 | 2448 | 0.130 |
Why?
|
| Transcription Factors | 5 | 2003 | 12150 | 0.120 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2021 | 2510 | 0.120 |
Why?
|
| Myosin Type V | 1 | 2014 | 31 | 0.110 |
Why?
|
| Muscle Relaxation | 1 | 2014 | 138 | 0.110 |
Why?
|
| Ristocetin | 1 | 1992 | 26 | 0.110 |
Why?
|
| Penis | 1 | 2014 | 209 | 0.100 |
Why?
|
| Insulin | 1 | 2007 | 6608 | 0.100 |
Why?
|
| Myosin Heavy Chains | 1 | 2014 | 403 | 0.100 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1992 | 282 | 0.100 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 2 | 2003 | 129 | 0.100 |
Why?
|
| Hep G2 Cells | 1 | 2012 | 378 | 0.090 |
Why?
|
| Point Mutation | 3 | 2002 | 1591 | 0.090 |
Why?
|
| Polymorphism, Genetic | 4 | 2010 | 4249 | 0.090 |
Why?
|
| RNA, Messenger | 2 | 2021 | 12791 | 0.090 |
Why?
|
| Muscle, Smooth | 1 | 2014 | 931 | 0.080 |
Why?
|
| Sweetening Agents | 1 | 2012 | 291 | 0.080 |
Why?
|
| Gene Expression Regulation | 2 | 2007 | 11920 | 0.080 |
Why?
|
| Sulfates | 1 | 1990 | 380 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 1990 | 2839 | 0.080 |
Why?
|
| CHO Cells | 4 | 2007 | 1376 | 0.080 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2003 | 326 | 0.080 |
Why?
|
| Binding Sites | 4 | 2003 | 6012 | 0.080 |
Why?
|
| Coronary Disease | 1 | 2003 | 5915 | 0.080 |
Why?
|
| Protease Inhibitors | 2 | 1990 | 750 | 0.080 |
Why?
|
| Cricetinae | 4 | 2007 | 2416 | 0.080 |
Why?
|
| Metalloendopeptidases | 1 | 1990 | 386 | 0.070 |
Why?
|
| Cricetulus | 2 | 2007 | 810 | 0.070 |
Why?
|
| 5' Untranslated Regions | 1 | 2007 | 255 | 0.060 |
Why?
|
| Endotoxins | 1 | 1988 | 519 | 0.060 |
Why?
|
| Nitric Oxide | 1 | 2014 | 2141 | 0.060 |
Why?
|
| COUP Transcription Factors | 1 | 2003 | 4 | 0.060 |
Why?
|
| Base Sequence | 3 | 2007 | 12415 | 0.050 |
Why?
|
| COUP Transcription Factor II | 1 | 2003 | 19 | 0.050 |
Why?
|
| Poland | 2 | 2000 | 197 | 0.050 |
Why?
|
| RNA, Small Interfering | 1 | 2012 | 3425 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2007 | 2326 | 0.050 |
Why?
|
| Codon | 2 | 2000 | 599 | 0.050 |
Why?
|
| Molecular Sequence Data | 4 | 2007 | 17608 | 0.050 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2003 | 309 | 0.050 |
Why?
|
| Introns | 1 | 2003 | 966 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 2 | 2001 | 663 | 0.040 |
Why?
|
| Recombinant Proteins | 4 | 2000 | 6507 | 0.040 |
Why?
|
| Consanguinity | 2 | 2001 | 460 | 0.040 |
Why?
|
| DNA | 2 | 2007 | 7208 | 0.040 |
Why?
|
| Binding, Competitive | 1 | 2000 | 1141 | 0.040 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2000 | 705 | 0.040 |
Why?
|
| Animals | 12 | 2021 | 168930 | 0.040 |
Why?
|
| Genotype | 3 | 2003 | 13036 | 0.040 |
Why?
|
| Frameshift Mutation | 1 | 2000 | 392 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2007 | 17088 | 0.040 |
Why?
|
| Cells, Cultured | 3 | 2003 | 18984 | 0.040 |
Why?
|
| DNA Mutational Analysis | 3 | 2001 | 4114 | 0.040 |
Why?
|
| Mice | 7 | 2021 | 81889 | 0.040 |
Why?
|
| Exons | 1 | 2003 | 2392 | 0.040 |
Why?
|
| Haplotypes | 1 | 2003 | 2727 | 0.030 |
Why?
|
| Mutation | 2 | 1999 | 30213 | 0.030 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1996 | 67 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 1742 | 0.030 |
Why?
|
| Calmodulin-Binding Proteins | 1 | 1996 | 238 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 1996 | 327 | 0.030 |
Why?
|
| Heterozygote | 1 | 2000 | 2795 | 0.030 |
Why?
|
| Nitric Oxide Donors | 1 | 2014 | 123 | 0.030 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2014 | 262 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2014 | 175 | 0.030 |
Why?
|
| Nuclear Proteins | 3 | 1996 | 5795 | 0.030 |
Why?
|
| Mice, Inbred DBA | 1 | 2014 | 624 | 0.030 |
Why?
|
| Structure-Activity Relationship | 2 | 2001 | 3053 | 0.030 |
Why?
|
| Liver Neoplasms | 2 | 2007 | 4353 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 1998 | 2870 | 0.030 |
Why?
|
| Alleles | 1 | 2003 | 6895 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1998 | 3073 | 0.020 |
Why?
|
| Risk | 1 | 2003 | 9602 | 0.020 |
Why?
|
| Chlorates | 1 | 1990 | 12 | 0.020 |
Why?
|
| Sulfur Radioisotopes | 1 | 1990 | 113 | 0.020 |
Why?
|
| Humans | 15 | 2012 | 766766 | 0.020 |
Why?
|
| Peptide Mapping | 1 | 1990 | 259 | 0.020 |
Why?
|
| Methylhydrazines | 1 | 1990 | 6 | 0.020 |
Why?
|
| Trypsin Inhibitor, Bowman-Birk Soybean | 1 | 1990 | 3 | 0.020 |
Why?
|
| Dimethylhydrazines | 1 | 1990 | 12 | 0.020 |
Why?
|
| Trypsin Inhibitors | 1 | 1990 | 32 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1992 | 1431 | 0.020 |
Why?
|
| Herbicides | 1 | 1990 | 104 | 0.020 |
Why?
|
| Trypsin | 1 | 1990 | 490 | 0.020 |
Why?
|
| NFATC Transcription Factors | 3 | 1996 | 392 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1990 | 292 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 1999 | 2590 | 0.020 |
Why?
|
| Glycosylation | 1 | 1992 | 1099 | 0.020 |
Why?
|
| Platelet Aggregation | 1 | 1992 | 769 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1990 | 634 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 1990 | 526 | 0.020 |
Why?
|
| Protein Binding | 3 | 2002 | 9320 | 0.020 |
Why?
|
| Cell Line | 4 | 1996 | 15563 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2003 | 12534 | 0.020 |
Why?
|
| Hydrolysis | 1 | 1990 | 645 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 1996 | 13411 | 0.020 |
Why?
|
| Serine Endopeptidases | 2 | 1990 | 1027 | 0.020 |
Why?
|
| Fibroblasts | 2 | 1990 | 4166 | 0.020 |
Why?
|
| Stroke | 1 | 2010 | 9741 | 0.020 |
Why?
|
| Molecular Weight | 1 | 1990 | 2168 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1996 | 2571 | 0.020 |
Why?
|
| Homozygote | 2 | 2002 | 1775 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 1990 | 1750 | 0.020 |
Why?
|
| Heparin | 1 | 1992 | 1636 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 1996 | 5503 | 0.020 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1990 | 2478 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1992 | 2201 | 0.010 |
Why?
|
| Male | 7 | 2014 | 364142 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 1990 | 1227 | 0.010 |
Why?
|
| Collagen | 1 | 1992 | 2635 | 0.010 |
Why?
|
| Endopeptidases | 1 | 1987 | 762 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 2001 | 4168 | 0.010 |
Why?
|
| Chromogenic Compounds | 1 | 2002 | 29 | 0.010 |
Why?
|
| Hemorrhagic Disorders | 1 | 2002 | 34 | 0.010 |
Why?
|
| Factor X | 1 | 2002 | 64 | 0.010 |
Why?
|
| Clone Cells | 2 | 1996 | 1670 | 0.010 |
Why?
|
| Myocardial Infarction | 1 | 2003 | 11513 | 0.010 |
Why?
|
| T-Lymphocytes | 2 | 1996 | 10264 | 0.010 |
Why?
|
| Cytokines | 1 | 1996 | 7438 | 0.010 |
Why?
|
| Base Pair Mismatch | 1 | 2001 | 93 | 0.010 |
Why?
|
| Catalysis | 1 | 2002 | 767 | 0.010 |
Why?
|
| Thromboplastin | 1 | 2002 | 289 | 0.010 |
Why?
|
| Hydrogen Bonding | 1 | 2001 | 290 | 0.010 |
Why?
|
| Adult | 4 | 2010 | 223307 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 1990 | 4424 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 1999 | 6066 | 0.010 |
Why?
|
| Valine | 1 | 1999 | 410 | 0.010 |
Why?
|
| Jews | 1 | 1999 | 359 | 0.010 |
Why?
|
| Factor VIIa | 1 | 1997 | 103 | 0.010 |
Why?
|
| Italy | 1 | 1999 | 856 | 0.010 |
Why?
|
| Ionomycin | 1 | 1996 | 109 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1996 | 220 | 0.010 |
Why?
|
| Alanine | 1 | 1999 | 613 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 1999 | 697 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1988 | 10745 | 0.010 |
Why?
|
| COS Cells | 1 | 1997 | 1135 | 0.010 |
Why?
|
| Calcium | 2 | 2001 | 5783 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2014 | 22352 | 0.010 |
Why?
|
| Calcineurin | 1 | 1996 | 235 | 0.010 |
Why?
|
| Kinetics | 1 | 2002 | 6287 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1997 | 1989 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 3757 | 0.010 |
Why?
|
| Gene Transfer Techniques | 1 | 1999 | 1206 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2001 | 3947 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1996 | 891 | 0.010 |
Why?
|
| Proteins | 1 | 1987 | 6002 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 1996 | 1155 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2001 | 3738 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1996 | 2746 | 0.010 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1996 | 1442 | 0.010 |
Why?
|
| DNA Primers | 1 | 1996 | 2826 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1996 | 1505 | 0.010 |
Why?
|
| Middle Aged | 2 | 2003 | 223257 | 0.010 |
Why?
|
| Pedigree | 1 | 1999 | 4539 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2001 | 5386 | 0.010 |
Why?
|
| Female | 4 | 2010 | 396520 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 1996 | 1749 | 0.010 |
Why?
|
| Triglycerides | 1 | 1997 | 2441 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 1996 | 1895 | 0.010 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 1990 | 190 | 0.000 |
Why?
|
| Tumor Cells, Cultured | 1 | 1996 | 6104 | 0.000 |
Why?
|
| Isoflurophate | 1 | 1987 | 27 | 0.000 |
Why?
|
| Mice, Inbred Strains | 1 | 1990 | 1767 | 0.000 |
Why?
|
| Coumarins | 1 | 1987 | 119 | 0.000 |
Why?
|
| Gene Expression | 1 | 1999 | 7585 | 0.000 |
Why?
|
| Mice, Inbred C3H | 1 | 1987 | 915 | 0.000 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 1987 | 174 | 0.000 |
Why?
|
| Phosphorylation | 1 | 1996 | 8307 | 0.000 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1996 | 4349 | 0.000 |
Why?
|
| Organ Size | 1 | 1990 | 2261 | 0.000 |
Why?
|
| Young Adult | 1 | 2010 | 59939 | 0.000 |
Why?
|
| Pancreas | 1 | 1990 | 1698 | 0.000 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 1990 | 957 | 0.000 |
Why?
|
| Oligopeptides | 1 | 1987 | 1195 | 0.000 |
Why?
|
| Body Weight | 1 | 1990 | 4626 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2001 | 42577 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1990 | 4049 | 0.000 |
Why?
|
| Adenocarcinoma | 1 | 1990 | 6359 | 0.000 |
Why?
|